Jean-Jacques Mazeron
Overview
Explore the profile of Jean-Jacques Mazeron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borius P, Amelot A, Boustany E, Boskos C, Mazeron J, Valery C
Eur J Surg Oncol
. 2023 Oct;
49(11):107043.
PMID: 37856987
Background: Gammaknife radiosurgery (GKRS) is a valuable option to control cerebral metastases. However, the risk (adverse radiation effect (ARE))-benefit (local control (LC)) ratio switches when the target is too large....
2.
Rougier G, Rochand A, Bourdais R, Meillan N, Tankere F, Herman P, et al.
Laryngoscope
. 2022 May;
133(3):607-614.
PMID: 35638238
Objectives: Head & Neck Paragangliomas have been historically relying on surgery mostly, with worsened quality of life and major sequelae. Conventional external radiation therapy seems to offer an equivalent control...
3.
Petit C, Lacas B, Pignon J, Le Q, Gregoire V, Grau C, et al.
Lancet Oncol
. 2021 Apr;
22(5):727-736.
PMID: 33862002
Background: Randomised, controlled trials and meta-analyses have shown the survival benefit of concomitant chemoradiotherapy or hyperfractionated radiotherapy in the treatment of locally advanced head and neck cancer. However, the relative...
4.
Lacas B, Carmel A, Landais C, Wong S, Licitra L, Tobias J, et al.
Radiother Oncol
. 2021 Jan;
156:281-293.
PMID: 33515668
Background And Purpose: The Meta-Analysis of Chemotherapy in squamous cell Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved overall survival (OS) in patients without distant metastasis. We...
5.
Dauzier E, Lacas B, Blanchard P, Le Q, Simon C, Wolf G, et al.
Oral Oncol
. 2019 Jul;
95:106-114.
PMID: 31345376
Objective: To evaluate the effect of chemotherapy added to a surgical locoregional treatment (LRT) for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Materials And Methods: We...
6.
Klausner G, Troussier I, Biau J, Jacob J, Schernberg A, Canova C, et al.
Clin Genitourin Cancer
. 2019 Mar;
17(3):191-200.
PMID: 30926219
Background: The objective of the study was to evaluate the outcomes in terms of efficacy and safety of a large consecutive series of 362 patients with renal cell carcinoma (RCC)...
7.
Boulle G, Bracci S, Hitchcock K, Jacob J, Clausse E, Halley A, et al.
J Clin Neurosci
. 2018 Dec;
59:190-196.
PMID: 30528356
Meningiomas account for 30-35% of intracranial tumors. Grade I meningiomas are most common and carry the best prognosis. Grade II and III meningiomas are more aggressive and the outcomes after...
8.
Jacob J, Durand T, Feuvret L, Mazeron J, Delattre J, Hoang-Xuan K, et al.
Radiother Oncol
. 2018 Jul;
128(2):221-228.
PMID: 30041961
Life expectancy of patients treated for brain tumors has lengthened due to the therapeutic improvements. Cognitive impairment has been described following brain radiotherapy, but the mechanisms leading to this adverse...
9.
Roger A, Finet A, Boru B, Beauchet A, Mazeron J, Otzmeguine Y, et al.
Oncoimmunology
. 2018 Jul;
7(7):e1442166.
PMID: 30034949
Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced melanoma patients treated simultaneously with radiotherapy and anti-PD-1...
10.
Amelot A, Terrier L, Mathon B, Cook A, Mazeron J, Valery C, et al.
Med Oncol
. 2018 Feb;
35(3):35.
PMID: 29427159
Brain metastases natural history from one primary tumor type might be accelerated or favored by using certain systemic chemotherapy. A great deal was described in mice and suggested in human...